BME
$36.59
BlackRock Health Sciences Trust
Fund Family: BlackRock Health Sciences Trust
1 Month
+0.83%
YTD
-6.53%
1 Year
-6.53%
3 Year
+6.00%
Top 10 Holdings (46.2% of portfolio)
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | Manufacturing | 7.99% |
| 2 | AbbVie Inc. | ABBV | Manufacturing | 6.88% |
| 3 | Boston Scientific Corp. | BSX | Manufacturing | 5.41% |
| 4 | UnitedHealth Group Inc | UNH | Finance and Insurance | 5.23% |
| 5 | Abbott Laboratories | ABT | Manufacturing | 4.73% |
| 6 | Thermo Fisher Scientific Inc. | TMO | Professional, Scientific, and Technical Services | 3.53% |
| 7 | Stryker Corp. | SYK | Manufacturing | 3.37% |
| 8 | Gilead Sciences Inc | GILD | Manufacturing | 3.04% |
| 9 | Amgen Inc | AMGN | Manufacturing | 3.02% |
| 10 | Johnson & Johnson | JNJ | Manufacturing | 3.00% |
Fund Information
| Net Assets | $538.61M | Expense Ratio | N/A |
| Total Holdings | 119 | Annual Fee* | N/A |
| Inception Date | N/A | Fund Family | BlackRock Health Sciences Trust |
*Annual fee per $10,000 invested